Vertex to Participate in Upcoming June Investor Conferences

Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) will take part in two upcoming investor conferences in June 2024. CEO Dr. Reshma Kewalramani will present at the William Blair 44th Annual Growth Stock Conference on June 4 at 4:00 p.m. CT. Executives Charles Wagner and Dr. David Altshuler will join a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11 at 11:20 a.m. ET. Both events will be webcast live on the Vertex website, with replays available afterward.

Positive

• Participation in high-profile investor conferences can boost investor confidence.
• Live webcasts increase transparency and provide real-time updates to investors.
• Replay availability ensures broader access to important information for potential and existing investors.

Negative

• No new financial or clinical data were announced, potentially leaving investors wanting more substantive updates.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.

• Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the William Blair 44^th Annual Growth Stock Conference on Tuesday, June 4, 2024 at 4:00 p.m. CT.
• Charles Wagner, Executive Vice President and Chief Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer, will participate in a fireside chat at the Goldman Sachs 45^th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 11:20 a.m. ET.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522554872/en/

Vertex Pharmaceuticals Incorporated

Investors:

InvestorInfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals participate in the William Blair 44th Annual Growth Stock Conference?

Dr. Reshma Kewalramani will present on June 4, 2024, at 4:00 p.m. CT.

When is the Goldman Sachs 45th Annual Global Healthcare Conference?

The event will occur on June 11, 2024, with Vertex executives participating at 11:20 a.m. ET.

How can investors watch the live webcasts of Vertex's conferences?

Webcasts will be available on the Vertex website under the 'Investors' section on the 'News and Events' page.

Will the Vertex conference webcasts be available for replay?

Yes, replays will be archived on the company's website.

What is the stock symbol for Vertex Pharmaceuticals?

The stock symbol for Vertex Pharmaceuticals is VRTX.